Thursday, biocides company Arch Chemicals Inc. (ARJ) reported a profit in its fourth quarter, compared to a loss a year ago, helped by higher revenue. Looking ahead, the company issued fiscal 2010 financial outlook.
The Norwalk, Connecticut-based company reported fourth-quarter net income of $2.7 million or $0.11 per share, compared to a loss of $18.9 million or $0.75 per share last year.
On average, four analysts polled by Thomson Reuters expected the company to report a loss of $0.04 per share for the quarter. Analysts' estimates typically exclude special items.
Sales were $333.5 million compared to $307.5 million last year. Two analysts had a revenue consensus of $313.90 million for the fourth quarter.
Segment wise, sales for treatment products rose to $290.4 million from $260.5 million in the year-ago period. Performance products segment sales declined to $43.1 million from $47.0 million in the year ago period.
For the full year of 2009, Arch Chemicals reported net income of $47.1 million or $1.88 per share, compared to net income of $37.0 million or $1.49 per share. Excluding the severance charge, net income was $1.91 per share compared to $2.49 per share for 2008.
Revenue in 2009 declined to $1.39 billion from $1.49 billion in 2008.
Analysts were looking for earnings of $1.70 per share on revenues of $1.37 billion for fiscal 2009.
Looking ahead for fiscal 2010, the company expects sales to increase by approximately 8% to 10% as a result of strong organic growth from the biocides businesses. Earnings per share are forecast to be in the $1.90 to $2.10 range.
Analysts currently expect earnings of $1.93 on revenues of $1.43 billion for fiscal 2010.
ARJ closed Thursday's regular trading at $28.53, up $0.51 or 1.82% on a volume of 158 thousand shares.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.